Rare diseases
Investigational molecules
Locations
Back to Belgium1 305 clinical trials in Charleroi, Belgium across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on Maribavir for Treating Cytomegalovirus in Children and Adolescents Post-Transplant
BelgiumStudy of Tucatinib, Trastuzumab, and Pertuzumab for Patients with Advanced or Metastatic HER2+ Breast Cancer
BelgiumStudy of EPI-7386 and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer
BelgiumStudy on the Effects of SAR443820 and Gadobutrol in Patients with Multiple Sclerosis
BelgiumStudy on AVP-786 for Treating Agitation in Alzheimer's Dementia Patients
BelgiumStudy of Datopotamab Deruxtecan and Pembrolizumab for Patients with Advanced or Metastatic Non-small Cell Lung Cancer Without Actionable Genomic Alterations
BelgiumStudy of BT5528 alone and with nivolumab in patients with advanced solid tumors that have EphA2 protein expression
BelgiumStudy on Epcoritamab, Rituximab, and Lenalidomide for Adults with Untreated Follicular Lymphoma
BelgiumStudy on the Safety and Effectiveness of Vepdegestrant and PF-07220060 for Adults with ER+/HER2- Advanced or Metastatic Breast Cancer
BelgiumStudy on Mosunetuzumab and Lenalidomide for Patients with Untreated Follicular Lymphoma
BelgiumStudy of ALX148 and Pembrolizumab for Patients with Advanced Head and Neck Cancer
BelgiumStudy of Lacutamab Alone or with Chemotherapy for Patients with Advanced T-Cell Lymphoma
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on advanced cancer treatments, particularly in breast cancer, lung cancer, and head and neck cancers. Studies evaluate novel therapeutic approaches including immunotherapy combinations and targeted treatments.
Multiple trials investigating personalized medicine approaches and biomarker-driven treatments.
Research examining treatments for coronary artery disease and post-cardiac arrest care. Trials focus on innovative stent technologies and antiplatelet therapy optimization.
Emphasis on improving patient outcomes through targeted interventional approaches.
Clinical investigations targeting inflammatory skin conditions and immune-mediated disorders. Studies evaluate novel treatments for psoriasis and other dermatological conditions.
Focus on developing targeted therapies for chronic inflammatory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
